Fortress Biotech, Inc., 10% Owner at AVENUE THERAPEUTICS, INC. (ATXI), bought 836,820 shares at $0.72 ($603K) on 2023-09-08, disclosed to the SEC on 2023-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.72 | 418,410 | $301K | 50.0% |
| 2 | $0.72 | 418,410 | $301K | 50.0% |
| Total | $0.72 avg | 836,820 | $603K | 100% |